11-17779610-G-T
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 1P and 18B. PP2BP4_ModerateBP6_Very_StrongBS1BS2
The NM_001112741.2(KCNC1):c.1659G>T(p.Glu553Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000388 in 1,550,372 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001112741.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNC1 | NM_001112741.2 | c.1659G>T | p.Glu553Asp | missense_variant | 3/4 | ENST00000265969.8 | NP_001106212.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNC1 | ENST00000265969.8 | c.1659G>T | p.Glu553Asp | missense_variant | 3/4 | 5 | NM_001112741.2 | ENSP00000265969.7 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000242 AC: 37AN: 152942Hom.: 0 AF XY: 0.000197 AC XY: 16AN XY: 81154
GnomAD4 exome AF: 0.000412 AC: 576AN: 1398168Hom.: 0 Cov.: 31 AF XY: 0.000381 AC XY: 263AN XY: 689618
GnomAD4 genome AF: 0.000164 AC: 25AN: 152204Hom.: 0 Cov.: 33 AF XY: 0.000202 AC XY: 15AN XY: 74350
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 27, 2017 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Progressive myoclonic epilepsy type 7 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 22, 2023 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 07, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at